The most common risks of oral GLP-1s like Rybelsus, Wegovy pill, and Foundayo include : Acute pancreatitis Diabetic retinopathy complications (diabetes-related vision changes) Hypoglycemia (low blood sugar), especially when used with insulin Kidney or gallbladder issues Severe gastrointestinal reactions Allergic reactions Pulmonary aspiration during general anesthesia or deep sedation All three GLP-1s also carry a black box warning for thyroid tumors based on animal studies
Vital sign monitors: Collect key data points related to comorbidities, such as heart disease
Recalls & Warnings April 11, 2008 Twelve Dietary Herbal Supplements Recalled -- Possible Health Risk Associated with Ephedra, Aristolochic Acid and Human Placenta On April 10, 2008, the FDA posted a recall notice issued the same day from Herbal Science International, Inc
Should be avoided in people with a carnitine transport disorder, such as primary systemic carnitine deficiency, as it may exacerbate the condition
